Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2635 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Covidien and Depomed sign licensing agreement

Under the licensing agreement between Depomed and Mallinckrodt, a subsidiary of Covidien, Depomed will receive a one-time upfront payment of $4 million, and could receive up to $64